Fetal Gender Test Insurance Coverage: What You Need To Know

what is the fetal gender test called for insurance

Non-invasive prenatal testing (NIPT) is a fetal gender test that can be used to determine the sex of a fetus. The test is typically done by taking a blood sample from the mother and analyzing the fetal DNA present in the sample. NIPT can be performed as early as 6 to 10 weeks into a pregnancy and has an accuracy rate of over 99%. The cost of NIPT can vary depending on insurance coverage, with out-of-pocket expenses ranging from several hundred to several thousand dollars. Some manufacturers offer reduced pricing for those who qualify for financial hardship discounts.

Characteristics Values
Name of Test Non-Invasive Prenatal Test (NIPT) or Cell-Free DNA Testing
Purpose Primarily a genetic screening tool to identify genetic conditions and abnormalities
Mechanism Detects the presence or absence of the male Y-chromosome in cell-free fetal DNA
Accuracy Over 99%
Timing Can be performed as early as 6-10 weeks into pregnancy
Cost Several hundred to several thousand dollars; not typically covered by insurance
Criteria for Insurance Coverage Female must be at least 35 years old at the time of delivery or have had a prior pregnancy with aneuploidy

shunins

Non-invasive prenatal tests (NIPTs)

NIPTs are typically performed through a blood draw taken at a regular prenatal checkup. They are considered safe for both the mother and the fetus, as they are non-invasive and carry none of the potential risks associated with other tests, such as amniocentesis and chorionic villus sampling (CVS), which carry a small risk of miscarriage. NIPT tests can be performed as early as 10 weeks into the pregnancy, with some tests, such as the SneakPeek Gender Test, claiming to be 99.9% accurate as early as 6 weeks into the pregnancy.

The cost of NIPTs varies, with out-of-pocket expenses ranging from several hundred to several thousand dollars. In Australia, for example, NIPT is not covered by Medicare or private health insurance. However, some manufacturers offer reduced pricing for those who qualify for financial hardship discounts.

While NIPTs can be used to determine the sex of the fetus, it is important to note that this is not their primary purpose. They are primarily genetic screening tools used to identify genetic conditions, some of which are sex-based. If one is interested only in determining the sex of the fetus, at-home sex DNA kits are available, which look only for male chromosomes.

shunins

At-home sex DNA kits

These kits work by analysing a small sample of the mother's blood for the presence of male chromosomes, specifically the Y chromosome. If a Y chromosome is detected, it indicates that the baby is a boy, and if not, it means the baby is a girl. The blood sample can be collected at home by pricking the finger and then sent to a lab for analysis. Results are typically communicated via email or SMS.

It is important to note that while these at-home tests can be convenient and exciting for parents, they are not always 100% accurate. There is a small margin of error, and factors such as DNA contamination, recent miscarriage, multiple pregnancies, or lab contamination can impact the accuracy of the results. Therefore, it is always recommended to consult a healthcare provider for more reliable and comprehensive genetic screening.

Some popular options for at-home sex DNA kits include:

  • SneakPeek Clinical: This test has been shown to be highly accurate, with published studies claiming 99.9% accuracy. It can be purchased online or at stores like Walmart, CVS, and Walgreens. The cost of the test is $149.
  • Peekaboo: This kit also uses a blood test as early as seven weeks into the pregnancy and claims 100% accuracy. Results are communicated via email within seven business days.
  • GENDERmaker: This is a urine-based test that provides instant results without the need to send samples to a lab. It can be used as early as six weeks into pregnancy.
  • AlphaBiolabs USA: Their Prenatal Gender Test is 99.9% accurate and reliable, and it only requires a blood sample from the mother. The test costs $99, and results are available in 3-4 business days.

shunins

Cell-free DNA screening

During pregnancy, some of the fetus's DNA circulates in the mother's bloodstream. A cell-free DNA screening test examines the chromosomes in this fetal DNA to determine the likelihood of the fetus having certain disorders. Chromosomes are tiny "packages" in cells that contain genes, which carry information called DNA that controls what we look like and how our bodies work. Typically, each cell has 46 chromosomes, grouped into 23 pairs, with each pair containing two chromosomes, one from each parent. If one of these pairs has an extra copy of a chromosome, it is called a trisomy, which can lead to conditions such as Down syndrome (trisomy 21), trisomy 18, or trisomy 13.

While cell-free DNA screening is considered a safe and accurate test, it is important to note that it is not 100% definitive. A negative result does not completely rule out the possibility of chromosomal disorders, and a positive result requires further diagnostic testing for confirmation. Additionally, the accuracy of the test may be impacted in cases of multiple pregnancies, such as with twins or triplets.

Although cell-free DNA screening is primarily a genetic screening tool, it can also be used to determine the sex of the fetus. This is because some genetic conditions are sex-based, and early knowledge of the baby's gender can enable healthcare providers to perform timely screenings for such conditions. However, it is important to note that the primary purpose of the test is not to determine the sex of the fetus, and there are other tests available specifically for that purpose, such as at-home sex DNA kits.

shunins

Chorionic villus sampling (CVS)

During the CVS procedure, a small sample of cells is removed from the placenta, which shares identical genetic material with the fetus. This can be done through two methods: transabdominal CVS, where a needle is inserted through the abdomen, or transcervical CVS, where a tube or small forceps are inserted through the cervix. The test itself takes about 10 minutes, although the whole consultation may take about 30 minutes. The placenta is a structure in the uterus that provides nutrients and blood from the mother to the baby. The chorionic villi, which are tiny projections of placental tissue, are accessed during the procedure to obtain the cell sample.

After the sample is collected, it is sent to a genetics lab for analysis. The baby's heart rate and the mother's vital signs are monitored during this time. Some women may experience slight cramping and light spotting for a few hours after the procedure. The first results of the test are typically available within three days. If the results indicate a high likelihood of a genetic condition, a specialist will explain the findings and discuss options, which may include ending the pregnancy or continuing with further information and preparation.

CVS is considered an alternative to amniocentesis, another prenatal test. Unlike amniocentesis, CVS can be performed earlier in the pregnancy, providing more time for counselling and decision-making. However, CVS does not provide information on neural tube defects, such as spina bifida, for which a follow-up blood test is required. CVS carries a small risk of miscarriage and other complications, which should be discussed with a healthcare provider before the procedure.

shunins

Amniocentesis

The procedure involves inserting a long, thin, 20- to 22-gauge spinal needle through the mother's abdominal wall, guided by an ultrasound image. The needle is passed into the amniotic sac and a small sample of amniotic fluid is removed for analysis. The test itself takes about 10 minutes, but the whole consultation may take about 30 minutes. Amniocentesis is described as uncomfortable rather than painful, with some women experiencing a pain similar to period pain or feeling pressure when the needle is withdrawn.

The risks associated with amniocentesis include infection and the need to repeat the procedure due to issues with the first sample. The risk of complications is higher if the test is carried out before the 15th week of pregnancy, so it is typically performed between the 15th and 20th weeks.

Frequently asked questions

Fetal gender testing is a way to determine the sex of your baby before birth.

There are several tests to determine fetal sex, including blood tests, at-home DNA kits, and ultrasound scans.

The cost of fetal gender tests varies. At-home DNA kits can range from \$149 to several hundred dollars, while blood tests and ultrasounds may be covered by insurance, depending on your plan and specific criteria.

Fetal gender tests can be performed as early as 6 weeks into a pregnancy, with some tests available as early as 10 weeks.

Fetal gender tests are claimed to be highly accurate, with some tests reporting over 99% accuracy. However, it's important to note that occasional false negatives or positives can occur, and further testing may be recommended.

Written by
Reviewed by

Explore related products

Share this post
Print
Did this article help you?

Leave a comment